{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T22:41:43Z","timestamp":1787611303295,"version":"build-2736575974"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T00:00:00Z","timestamp":1752624000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T00:00:00Z","timestamp":1752624000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Pleural mesothelioma (PM) is a lethal cancer often linked to asbestos exposure. The COVID-19 pandemic caused a global health crisis, raising concerns about its impact on cancer diagnoses and treatments. In response to the immense pressures on the healthcare system caused by the COVID-19 pandemic, many countries advised prioritizing essential healthcare services while postponing or suspending care considered non-emergent to prevent overburdening healthcare systems. This study assesses the impact of COVID-19 on the incidence, treatment, and overall survival of PM patients in the Netherlands between 2018 and 2022. Data were collected from the Netherlands Cancer Registry for 2,629 PM patients. Incidence, treatment patterns, and survival rates were analyzed using statistical methods, including Kruskal\u2013Wallis and log-rank tests. PM incidence dropped 13.2% in 2020 during the pandemic, with a 58.8% increase in patients receiving best supportive care and a decline in chemotherapy use (from\u00a039.4%\u00a0to\u00a032.0%). In 2021, diagnoses rebounded (+\u200915.2%), and immunotherapy use rose following its approval. However, no significant difference in overall survival was found between 2018 and 2022. COVID-19 led to a temporary decline in PM diagnoses and systemic treatments in 2020, followed by recovery in 2021. Despite these changes, overall survival rates remained stable.<\/jats:p>","DOI":"10.1038\/s41598-025-10054-6","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T23:22:15Z","timestamp":1752621735000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Pleural mesothelioma incidence and use of systemic treatment decreased during the COVID-19 pandemic in The Netherlands"],"prefix":"10.1038","volume":"15","author":[{"given":"Illaa","family":"Smesseim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Anne H.","family":"Douma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacobus A.","family":"Burgers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald A. M.","family":"Damhuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,16]]},"reference":[{"key":"10054_CR1","doi-asserted-by":"crossref","unstructured":"Deraco, M., Mesothelioma. Cancers (Basel), 2021. 13(13).","DOI":"10.3390\/cancers13133127"},{"issue":"13","key":"10054_CR2","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1056\/NEJMra1912719","volume":"385","author":"SM Janes","year":"2021","unstructured":"Janes, S. M., Alrifai, D. & Fennell, D. A. Perspectives on the treatment of malignant pleural mesothelioma. N. Engl. J. Med. 385(13), 1207\u20131218 (2021).","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10054_CR3","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1093\/carcin\/bgt166","volume":"34","author":"Y Sekido","year":"2013","unstructured":"Sekido, Y. Molecular pathogenesis of malignant mesothelioma. Carcinogenesis 34(7), 1413\u20131419 (2013).","journal-title":"Carcinogenesis"},{"key":"10054_CR4","doi-asserted-by":"publisher","first-page":"bcr2012007491","DOI":"10.1136\/bcr-2012-007491","volume":"203","author":"PH Madsen","year":"2013","unstructured":"Madsen, P. H., Laursen, C. B. & Davidsen, J. R. Diagnostic delay in malignant pleural mesothelioma due to physicians fixation on history with non-exposure to asbestos. BMJ Case Rep. 203, bcr2012007491 (2013).","journal-title":"BMJ Case Rep."},{"issue":"Suppl 1","key":"10054_CR5","doi-asserted-by":"publisher","first-page":"S28","DOI":"10.21037\/tlcr.2019.11.11","volume":"9","author":"N Alpert","year":"2020","unstructured":"Alpert, N., van Gerwen, M. & Taioli, E. Epidemiology of mesothelioma in the 21(st) century in Europe and the United States, 40 years after restricted\/banned asbestos use. Transl. Lung Cancer Res. 9(Suppl 1), S28\u2013S38 (2020).","journal-title":"Transl. Lung Cancer Res."},{"issue":"6","key":"10054_CR6","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.jtho.2023.01.095","volume":"18","author":"J Huang","year":"2023","unstructured":"Huang, J. et al. Global incidence, risk factors, and temporal trends of mesothelioma: A population-based study. J. Thorac. Oncol. 18(6), 792\u2013802 (2023).","journal-title":"J. Thorac. Oncol."},{"issue":"12","key":"10054_CR7","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1136\/thoraxjnl-2021-217709","volume":"77","author":"JP van Kooten","year":"2022","unstructured":"van Kooten, J. P. et al. Incidence, treatment and survival of malignant pleural and peritoneal mesothelioma: a population-based study. Thorax 77(12), 1260\u20131267 (2022).","journal-title":"Thorax"},{"key":"10054_CR8","unstructured":"Organization, W.H. WHO (World Health Organization) Coronavirus disease (COVID-2019) situation reports. 2020; Available from: https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019\/situation-reports."},{"key":"10054_CR9","unstructured":"Association, A.M., Factsheet: State Action Related to Delay and Resumption of \u201cElective\u201d Procedures During COVID-19 Pandemic (2020)."},{"key":"10054_CR10","doi-asserted-by":"publisher","first-page":"417","DOI":"10.2147\/CLEP.S463160","volume":"16","author":"NL Barclay","year":"2024","unstructured":"Barclay, N. L. et al. The Impact of the COVID-19 pandemic on incidence and short-term survival for common solid tumours in the United Kingdom: A cohort analysis. Clin. Epidemiol. 16, 417\u2013429 (2024).","journal-title":"Clin. Epidemiol."},{"key":"10054_CR11","unstructured":"Organization, W.H., Pulse Survey on Continuity of Essential Health Services During the COVID-19 Pandemic\u2014Interim Report 2020 (COVID-19: essential health services), p. 21."},{"key":"10054_CR12","unstructured":"(IKNL), I.K.N., Fewer Cancer Diagnoses in 2020 Due to COVID-19 Crisis in the Netherlands: First Decrease in Thirty Years (2022)."},{"key":"10054_CR13","unstructured":"Organization, W.H., Statement on the Fifteenth Meeting of the International Health Regulations (2005) Emergency Committee Regarding the Coronavirus Disease (COVID-19) Pandemic (2023). (2023)."},{"key":"10054_CR14","unstructured":"Rijksoverheid. Coronavirus tijdlijn. Available from: https:\/\/www.rijksoverheid.nl\/onderwerpen\/coronavirus-tijdlijn."},{"issue":"2","key":"10054_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2022.100471","volume":"7","author":"L Cantini","year":"2022","unstructured":"Cantini, L. et al. Erratum to \u201cEvaluation of COVID-19 impact on DELAYing diagnostic-therapeutic pathways of lung cancer patients in Italy (COVID-DELAY study): Fewer cases and higher stages from a real-world scenario\u201d: [ESMO Open 7(2), April 2022, 100406]. ESMO Open 7(2), 100471 (2022).","journal-title":"ESMO Open"},{"key":"10054_CR16","doi-asserted-by":"publisher","first-page":"1243261","DOI":"10.3389\/fpubh.2023.1243261","volume":"11","author":"L Fazzo","year":"2023","unstructured":"Fazzo, L. et al. Mortality rates from asbestos-related diseases in Italy during the first year of the COVID-19 pandemic. Front. Public Health 11, 1243261 (2023).","journal-title":"Front. Public Health"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-10054-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-10054-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-10054-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T11:28:28Z","timestamp":1757244508000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-10054-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,16]]},"references-count":16,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["10054"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-10054-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,16]]},"assertion":[{"value":"10 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the Ethics Review Committee of the Netherlands Cancer Registry, under approval number [K22.180_2].","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"25677"}}